医学
前列腺切除术
阶段(地层学)
淋巴结切除术
病态的
泌尿科
前列腺癌
前列腺
癌
前列腺癌
病理分期
癌症
外科
放射科
内科学
古生物学
生物
作者
Henry E. Parfitt,Joseph A. Smith,James P. Seaman,Richard G. Middleton
标识
DOI:10.1016/s0022-5347(17)52346-0
摘要
Patients with stage A2 carcinoma of the prostate are a heterogeneous population and not all of them progress to clinically manifest disease. We found a similar variability in terms of the pathological findings in a group of 34 patients with stage A2 disease undergoing pelvic lymphadenectomy and radical prostatectomy. While 8 patients (24 per cent) had metastatic disease on staging lymphadenectomy, 9 patients (27 per cent) had negative lymphadenectomy, with minimal or no residual tumor in the radical specimen. The histologic grade and extent of tumor on transurethral resection did not predict reliably patients with stage A2 disease and minimally invasive cancer at radical prostatectomy. It appears that present criteria for separating stage A tumors into focal and diffuse categories are adequate for selecting therapy for patients with incidental carcinoma of the prostate.
科研通智能强力驱动
Strongly Powered by AbleSci AI